Omega-3 Fatty Acids for Suicidal Behavior
The Carlat Psychiatry Report, Volume 5, Number 3, March 2007
https://www.thecarlatreport.com/newsletter-issue/tcprv5n3/
Issue Links: Learning Objectives | Editorial Information
Topics: Natural Medications
William Carpenter, MD
Omega-3 fatty acids have been studied in a number of psychiatric disorders, including autism, bipolar disorder, depression, and schizophrenia. A new study shows a possible benefit for patients with a history of self-harm.
You can't view details of this content, please login or buy subscription here
William Carpenter, MD
Editor-in-Chief, Schizophrenia Bulletin; Professor, Psychiatry and Pharmacology, and Director, Maryland Psychiatric Research Center University of Maryland School of Medicine, Baltimore
Dr. Carpenter has disclosed that he has served as a consultant to Alza, AstraZeneca, Janssen Pharmaceutica, Merck, Pfizer, and Solvay/Wyeth, and that he has received less than $5,000 for each consultancy. Dr. Carlat has reviewed and edited the content to ensure a balanced and unbiased presentation.